Table 1.
Baseline characteristics of studied eyes
| Characteristics | Normal VRI | VRI abnormalities |
|---|---|---|
| Eyes (%) | 59 (56%) | 46 (44%) |
| Individual IVI (%) | 85 (52.5%) | 77 (47.5%) |
| Phakic/pseudophakic | 47/12 | 40/6 |
| Type I diabetes, eyes (%) | 6 (37.5%) | 10 (62.5%) |
| Type II diabetes, eyes (%) | 53 (59.5%) | 36 (40.5%) |
| Baseline CRT, µm | 560.0±158.6 | 521.8±135.8 |
| Mean CRT 1 month after IVI, µm | 432.0±113.5a | 468.8±110.6b |
| Mean change of CRT, µm | −128.0±144.7c | −53.0±96.4c |
Notes:
a
p<0.001 for the comparison of mean CRT 1 month after IVI vs baseline CRT.
b
p<0.05 for the comparison of mean CRT 1 month after IVI vs baseline CRT.
c
p<0.001 for the comparison of normal VRI vs VRI abnormalities. Data presented as number, number (%), and mean ± SD.
Abbreviations: IVI, intravitreal anti-VEGF injection; CRT, central retinal thickness; VRI, vitreoretinal interface.